Edwards Wins FDA Advisers’ Backing for Wider Sapien Use

Edwards Lifesciences Corp. won the backing of U.S. advisers for an expanded use of the company’s Sapien heart valve as an alternative to open-heart surgery.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.